Found vs Regenics: Biology-First Plans vs Cash-Pay Compounds
Found vs Regenics answers a common question: do you want a biology-first, insurance-friendly program or a straightforward cash-pay route to compounded GLP-1s? Early verdict: choose Found if you want a personalized, medically supervised plan that accepts many insurance plans and can start as low as $39; choose Regenics if you want a nurse-practitioner overseen, cash-pay entry to compounded semaglutide or tirzepatide starting at $139 for the first month.
Start Found from as low as $39
What each provider is and how they deliver care
Found positions itself as a biology-first, personalized medically supervised weight loss program that builds plans around hormones, blood sugar, sleep, and behavior. Regenics describes nurse-practitioner-led GLP-1 care offering compounded semaglutide and tirzepatide, plus a Sermorelin peptide option. Both operate via telehealth and require a licensed clinician to determine clinical appropriateness.
Key differences at a glance
| Criteria | Found | Regenics |
|---|---|---|
| Approach | Biology-first personalized program targeting hormones, metabolism, lifestyle | Focused GLP-1 access with nurse-practitioner oversight and optional peptide therapy |
| Starting price | Get started for as low as $39 | Semaglutide $139 first month; tirzepatide $189 first month |
| Insurance | Most insurance now accepted; Found handles insurance paperwork for some plans | No insurance required to start; FSA/HSA eligible |
| Medication type | Branded GLP-1s and compounded GLP-1s offered; compounded not FDA-approved | Compounded semaglutide and tirzepatide; compounded not FDA-approved |
| Clinician model | Medical evaluation and personalized program; Rx subject to provider review and clinical eligibility | Licensed nurse practitioners review intake and oversee prescriptions |
Distinctive difference 1: Personalization and clinical scope
Found emphasizes a broad biology-first evaluation and tailors plans to an individual patient s metabolic biology, including hormones, blood sugar regulation, sleep, and behavioral factors. Regenics is more narrowly focused on prescribing compounded GLP-1s under nurse-practitioner oversight and offering a complementary peptide option. If personalization beyond medication choice matters, Found documents a wider clinical scope in its materials.
Distinctive difference 2: Pricing model and insurance handling
Found advertises affordable monthly plans and says you can get started for as low as $39, and that most insurance is now accepted with Found handling insurance paperwork for some users. Regenics promotes promotional first-month pricing for compounded semaglutide at $139 and tirzepatide at $189 with renewals higher unless otherwise stated. Regenics explicitly notes no insurance is required to start and that plans are FSA/HSA eligible. Found s materials also include detailed notes about insurance variability, copays, coinsurance and that advertised branded GLP-1 pricing often depends on commitments.
See Found membership pricing and insurance options
Distinctive difference 3: Medication sourcing and regulatory notes
Both providers offer compounded GLP-1s and include the regulatory qualifier that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Found also lists branded GLP-1s such as ways to access Wegovy or Zepbound through insurance programs in specific circumstances. Regenics highlights U.S. licensed compounding pharmacies and states its pharmacy network is LegitScript certified; Regenics also notes promotional pricing applies to the first month only and that renewals increase.
Distinctive difference 4: Clinician oversight and program extras
Regenics frames care as nurse-practitioner-led and adds Sermorelin peptide therapy as an optional add-on. Found frames care as personalized and medically supervised with a broader behavioral and metabolic program rather than medication delivery alone. Prescription issuance for both is subject to clinician review and clinical eligibility.
Practical pros and cons from the sources
Found pros include biology-based personalized plans, affordable flexible pricing, and a holistic whole-body approach. Found cons note results vary by individual and that compounded GLP-1s are not FDA-approved and not available in all states. Regenics pros include promotional low first-month pricing, no insurance required, free shipping for compounded meds, FSA/HSA eligibility, and a LegitScript certified pharmacy network. Regenics cons include that promotional pricing applies only to the first month, compounded meds are not FDA-approved as finished products, and renewals are higher.
Explore Regenics first-month pricing
How to choose between Found vs Regenics
Choose Found if you want a program that starts as low as $39, accepts most insurance in many cases, and emphasizes a biology-first, personalized medically supervised plan that targets hormones, metabolism, and lifestyle. Choose Regenics if you prefer a cash-pay entry point overseen by licensed nurse practitioners, want compounded semaglutide or tirzepatide with promotional first-month pricing, and value a LegitScript certified pharmacy network and a Sermorelin peptide option.
Start Regenics with nurse-practitioner oversight
Final summary
In this Found vs Regenics comparison, Found is best for people who want weight loss built around their biology and may benefit from insurance support and broader programmatic care. Regenics is best for patients seeking a straightforward cash-pay path to compounded GLP-1s with nurse-practitioner oversight and an optional peptide therapy. Remember that compounded medications are not FDA-approved as finished products and all prescriptions are subject to clinician review and clinical eligibility.
Choose Found if you want a personalized, insurance-friendly approach that starts as low as $39. Choose Regenics if you want straightforward cash-pay access to compounded semaglutide or tirzepatide with nurse-practitioner oversight and promotional first-month pricing.